TherapeuticsMD, Inc. (TXMD)
- Previous Close
2.0100 - Open
2.0200 - Bid 1.7200 x 100
- Ask 2.3800 x 100
- Day's Range
2.0000 - 2.0800 - 52 Week Range
1.8400 - 4.7200 - Volume
10,169 - Avg. Volume
23,401 - Market Cap (intraday)
23.987M - Beta (5Y Monthly) 1.07
- PE Ratio (TTM)
-- - EPS (TTM)
-0.7400 - Earnings Date Aug 12, 2024 - Aug 16, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
www.therapeuticsmd.com1
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: TXMD
Performance Overview: TXMD
Trailing total returns as of 5/13/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TXMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TXMD
Valuation Measures
Market Cap
23.41M
Enterprise Value
27.09M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
16.28
Price/Book (mrq)
0.80
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-7.96%
Return on Equity (ttm)
-23.90%
Revenue (ttm)
1.3M
Net Income Avi to Common (ttm)
-7.7M
Diluted EPS (ttm)
-0.7400
Balance Sheet and Cash Flow
Total Cash (mrq)
4.33M
Total Debt/Equity (mrq)
27.33%
Levered Free Cash Flow (ttm)
-34.19M
Research Analysis: TXMD
Company Insights: TXMD
TXMD does not have Company Insights